arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

USANA HEALTH SCIENCES INC

USNA
$13.91 ▼ -0.43 (-3.00%) at close
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
68 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
56
Health
Fair
Neutral
auto_awesome

Analytical Summary

USANA HEALTH SCIENCES INC shows mixed fundamentals. Consider comparing against peers in the Materials sector before making investment decisions.

Market Cap $257.1M
Dividend Yield —
Revenue Growth -5.3% ↘
Op. Margin -9.0% ↘
ROIC -5.6% ↘
FCF / Share $1.09 ↗
Trailing P/E —
Price / Book 0.5x
FCF Yield 7.8%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

68-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$223.27M
↓ -5.3% —
Net Income Profit after all expenses
$-21.38M
↓ -384.5% —
Operating Margin Operating profit as % of sales
-9.0%
↓ -261.5% 40th
FCF / Share Free cash flow per share
$1.09
↑ +182.1% —

Health Breakdown

Profitability ↓
34
Returns ↓
48
Financial Health ↓
94
Cash Quality ↓
53

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 18 years · 68 quarters